Table 1– Demographics and possible risk factors for sleep disordered breathing
MalesFemalesAll
Subjects284270
Age years28.5±9.3 (18–53)34.1±13.6 (19–73)31.8±12.3 (18–73)
BMI kg·m−224.4±4.7 (15.3–37.9)25.1±6.6 (16.2–41.0)24.9±5.9 (15.3–41.0)
Mallampati score 1–42.9±0.7 (2.0–4.0)2.6±0.8 (1.0–4.0)2.7±0.7 (1.0–4.0)
STOP-Bang score 0–83.2±1.1 (1.0–6.0)2.3±1.2 (0.0–6.0)2.7±1.2 (0.0–6.0)
Buprenorphine
 Total dose mg21.5±17.5 (2.0–76.0)16.5±10.7 (2.0–48.0)18.5±13.0 (2.0–76.0)
 Dosage mg·h−10.4±0.2 (0.1–1.1)0.4±0.2 (0.1–1.1)0.4±0.2 (0.1–1.1)
  • Data are presented as n or mean±sd (range). BMI: body mass index; STOP-Bang: snore, tiredness, obstruction (witnessed apnoea), pressure (hypertension), BMI (>35 kg·m−2), age (>50) neck circumference >15.75 inches, gender (male).